Global Health Stock Screener | Share Price & Fundamental Analysis

MEDANTA Hospitals
Screen Global Health share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1238.50
▲ 29.60 (2.45%)
2026-01-07 00:00:00
Share Price BSE
₹1237.25
▲ 26.70 (2.21%)
2026-01-07 00:00:00
Market Cap ₹32,037.13 Cr.
P/E Ratio (TTM) 15.00
P/B Ratio 8.60
EPS (TTM) ₹17.92
Dividend Yield -
Debt to Equity 0.24
52W High ₹1428.30
52W Low ₹1001.60
Operating Margin 19.00%
Profit Margin 10.59%
Revenue (TTM) ₹954.00
EBITDA ₹198.00
Net Income ₹101.00
Total Assets ₹4,766.00
Total Equity ₹3,388.00
Last updated: Jan 07, 2026

Global Health Share Price History - Stock Screener Chart

Screen MEDANTA historical share price movements with interactive charts. Analyze price trends and patterns.

Global Health Company Profile - Fundamental Screener

Screen Global Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDANTA shares.
Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over 30 medical specialties, employed over 1,300 doctors, and had 2,467 installed beds across 4.7 million sq. ft. of area. The company operates hospitals in Gurugram, Indore, Ranchi, Lucknow, and Patna, with specialties including cardiology, neurosciences, oncology, and orthopedics. Global Health Limited went public in November 2022, raising Rs. 2205.57 crores through an IPO. The company has been expanding its facilities, adding beds, doctors, and new medical equipment across its hospitals.
Sector Healthcare Services
Industry Hospitals
Sub-Sector Hospitals
Segment E
Chairperson/CEO Naresh Kumar Trehan
ISIN INE474Q01031
Website https://www.medanta.org

Global Health Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen MEDANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018
Assets
Total Assets 4,766 4,304 4,116 3,146 2,694 0 2,430 1,984
Current Assets 1,533 1,509 1,580 812 502 0 489 472
Fixed Assets 2,514 2,236 2,050 1,776 1,616 0 1,194 1,094
Liabilities
Total Liabilities 4,766 4,304 4,116 3,146 2,694 0 2,430 1,984
Current Liabilities 760 781 1,115 1,110 907 0 839 432
Non-Current Liabilities 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 3,388 2,906 2,428 1,616 1,382 0 1,296 1,217
Share Capital 54 54 54 51 50 0 49 81
Reserves & Surplus 3,333 2,852 2,375 1,565 1,300 0 1,214 1,136

Global Health Income Statement Screener - Profit & Revenue Analysis

Intrinsic Value
Screen MEDANTA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept 2022-Dec
Revenue 954 1,051 1,119 836 883 975 960 732 795 865 855 533 627 695 706
Expenses 757 784 852 629 675 728 706 540 595 631 621 441 485 523 534
EBITDA 198 267 267 207 208 247 254 192 199 234 234 92 142 172 172
Operating Profit % 19.00% 24.00% 22.00% 22.00% 22.00% 24.00% 25.00% 24.00% 24.00% 25.00% 26.00% 15.00% 21.00% 23.00% 23.00%
Depreciation 49 45 50 46 47 49 49 38 40 43 44 35 36 37 39
Interest 15 14 17 18 18 16 16 21 18 20 18 28 19 18 21
Profit Before Tax 133 208 200 143 144 181 189 133 141 171 172 29 87 117 112
Tax 32 49 41 16 37 50 46 32 39 45 49 12 28 31 32
Net Profit 101 159 158 127 106 131 143 101 102 125 124 18 59 86 81
EPS 3.77 5.92 5.89 4.74 3.96 4.87 5.32 3.77 3.80 4.66 4.61 0.69 2.32 3.38 3.08

Global Health Cash Flow Screener - Liquidity Fundamentals

Screen MEDANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2016-March 2015-March
Operating Activities 624 612 645 311 242 175 166 63 228 213
Investing Activities -721 -441 -342 -421 -239 -87 -249 -69 -241 -126
Financing Activities -97 -514 346 160 -81 -1 97 9 -7 -88
Net Cash Flow -194 -343 648 50 -78 87 14 3 -20 0

Global Health Shareholding Pattern Screener - Ownership Analysis

Screen MEDANTA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Mar 2025-Jun 2025-Sept 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar
Promoter Holding 33.03% 33.01% 33.01% 33.04% 33.04% 33.04% 33.03% 33.08%
FII Holding 11.76% 11.54% 11.40% 12.09% 12.94% 12.20% 12.47% 0.00%
DII Holding 11.93% 12.20% 12.98% 10.25% 10.57% 11.11% 10.51% 12.35%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 6.53% 6.48% 6.03% 7.14% 6.28% 6.54% 6.74% 5.77%
Other Holding 36.75% 36.77% 36.58% 37.47% 37.16% 37.10% 37.24% 48.80%
Shareholder Count 154,688 156,372 155,806 166,253 155,307 149,722 148,633 107,120

Global Health Dividend Screener - Share Yield Analysis

Screen MEDANTA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
No dividends declared by Global Health.

Global Health Index Membership - Market Screener Classification

Screen MEDANTA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX BSEIPO
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MSL400
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY LARGEMID250
NIFTY MIDCAP 150
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH

Global Health Market Events Screener - Corporate Actions

Screen MEDANTA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -6.51%
Annual General Meeting NA 2.14%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -5.04%
2025-08-22 2025-08-22 Dividend ₹ 0.50 /share 11.88%
2025-08-07 2025-08-07 Quarterly Result Announcement NA -1.20%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 3.17%
2025-02-04 2025-02-04 Quarterly Result Announcement NA 4.13%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -3.80%
2024-08-03 2024-08-03 Extraordinary General Meeting NA -7.46%

Global Health Competitors Screener - Peer Comparison

Screen MEDANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 102,252 58.57 21,994 14.76% 1,505 46.86
Max Healthcare Institute 102,082 74.90 7,184 28.65% 1,076 38.86
Fortis Healthcare 67,988 64.26 7,850 13.25% 809 49.90
Narayana Hrudayalaya 39,532 45.71 5,575 12.29% 790 57.19
Global Health 32,037 56.77 3,771 12.59% 481 51.45
Aster DM Healthcare 31,434 87.54 4,287 15.12% 337 40.34
Krishna Institute of Medical Sciences 24,653 68.29 3,067 21.98% 415 33.50
Dr. Agarwal's Health Care 15,831 110.83 1,757 27.64% 110 47.42
Kovai Medical Center Hospital 13,964 27.53 600 11.69% 58 34.31
Rainbow Childrens Medicare 13,359 52.58 1,567 17.46% 244 41.00

Global Health Company Announcements - News Screener

Screen MEDANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-01-01 Closure of Trading Window View
2025-12-16 Announcement under Regulation 30 (LODR)-Credit Rating View
2025-12-16 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-12-15 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-12-09 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-12-05 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-12-03 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-27 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-13 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2025-11-11 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-11 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-11 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-11-11 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
Back to Screener